Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1995
11/22/1995CN1112123A 5-methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4T)
11/22/1995CN1112013A Disinfecting anti-inflammatory pill and its preparing method
11/22/1995CN1111984A Bath lotion series with anti-inflammatory, antipruritic and antibiotic functions
11/21/1995US5468888 Lupane derivatives, their preparation and the pharmaceutical compositions which contain them
11/21/1995US5468869 Process for production of (azolylmethyl)-(biphenylmethyl)cyclopentanol derivatives
11/21/1995US5468487 Extracted substance having anti-HIV activity
11/21/1995CA2149703A1 Mucosal administration of pneumococcal antigens
11/21/1995CA2149345A1 Epitopic regions of pneumococcal surface protein a
11/21/1995CA1337596C Varicella-zoster virus as a live recombinant vaccine
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof
11/16/1995WO1995030751A1 Lanthionine-containing antimicrobial compound
11/16/1995WO1995030692A1 Anti-fungal cyclic depsipeptides
11/16/1995WO1995030670A2 Pyranone compounds useful to treat retroviral infections
11/16/1995WO1995030641A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
11/16/1995WO1995030640A1 Substituted fused and bridged bicyclic compounds as therapeutic agents
11/16/1995WO1995030440A1 Keratin-storable antifungal composition for external use
11/16/1995WO1995030437A1 Improved modified live brsv vaccine
11/16/1995WO1995030422A1 Controlled-release dosage forms of azithromycin
11/16/1995WO1995030417A1 Potentiated antibiotic composition
11/16/1995DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines
11/16/1995CA2189129A1 Anti-fungal cyclic depsipeptides
11/16/1995CA2186621A1 Lanthionine-containing antimicrobial compound
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
11/15/1995EP0682030A1 8-Amino-10(azabicycloalkyl)-pyrido[1,2,3-d,e] [1,3,4] benzoxadiazine derivatives, process for their preparation and antibacterial agents containing them
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995EP0681586A1 Oligodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds
11/15/1995EP0681483A1 Compositions and methods for delivery of genetic material
11/15/1995EP0681482A1 Localization of therapeutic agents
11/15/1995EP0681470A1 Recombinant living subunit vaccine composition and process for its preparation.
11/15/1995EP0532668B1 Novel alpha-glucosidase inhibitors
11/15/1995EP0489096B1 Pharmaceutical compositions and a device for administering the same
11/15/1995EP0484333B1 Nucleoside derivatives and their use as medicaments
11/15/1995CN1111640A Lipopeptide derivatives, a process for their preparation and their use
11/15/1995CN1111639A Liponucleotide compounds
11/15/1995CN1111633A Process for preparing cephalosporin compounds from reactive organic acid derivatives
11/15/1995CN1111629A 5-vinyl- and 5-ethinyl-quinolone- and -naphthyridone-carboxyhic acids
11/15/1995CN1111513A Fungicidal compositions containing bifonazole
11/15/1995CN1111509A Protracted-release administration forms containing clindamycin palmitate
11/14/1995US5466820 Production of Di or tri-azolyl substituted 5-keto azole compounds
11/14/1995US5466686 Microbiocides
11/14/1995US5466684 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
11/14/1995US5466677 Dinucleoside phosphinates and their pharmaceutical compositions
11/14/1995US5466675 Immunological activity of rhamnolipids
11/14/1995US5466450 From Kibdelosporangium, treatment of herpes simplex
11/14/1995US5466449 Antibacterial composition and method of use
11/14/1995CA1337564C 7-(1-pyrrolidinyl)-quinolonecarboxylic acid derivatives and their use as antibacterials and animal feed utilization promoters
11/12/1995CA2148866A1 8-amino-10-(azabicycloalkyl)-pyrido[1,2,3-d,e][1,3,4] benzoxadiazine derivatives
11/12/1995CA2148865A1 8-amino-pyrido(1,2,3-d,e)(1,3,4)benzoxadiazine derivatives
11/09/1995WO1995030019A1 Feline immunodeficiency virus vaccine
11/09/1995WO1995029937A1 A new 78 residue polypeptide (nk-lysine) and its use
11/09/1995WO1995029934A1 Method of separating protective components of bordetella pertussis
11/09/1995WO1995029929A1 Novel erythromycin derivatives, method for their preparation and their use as drugs
11/09/1995WO1995029923A1 Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
11/09/1995WO1995029922A1 Methanol derivatives for treatment of retroviral infections especially hiv infections
11/09/1995WO1995029916A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/09/1995WO1995029894A1 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials
11/09/1995WO1995029702A1 Texaphyrin solid-supports and devices
11/09/1995WO1995029700A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/09/1995DE4415743A1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/09/1995CA2189045A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/09/1995CA2188918A1 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials
11/09/1995CA2188424A1 Method of separating protective components of bordetella pertussis
11/09/1995CA2187949A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/08/1995EP0680969A2 Modified oligonucleotides, their preparation and their use
11/08/1995EP0680967A1 Erythromycin derivatives, their process of preparation and their use as medicaments
11/08/1995EP0680765A1 Vaccine for nontypable haemophilus influenzae strain
11/08/1995EP0680745A2 Use of antifungals and or halogenated antibacterial agents for diminishing hair loss
11/08/1995EP0680512A1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
11/08/1995EP0680489A1 Foldback triplex-forming oligonucleotides
11/08/1995EP0680468A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation
11/08/1995EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase
11/08/1995EP0680324A1 Method and composition employing (2r,4s) itraconazole
11/08/1995EP0680322A1 Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
11/08/1995EP0306496B1 Method for reducing the toxicity of lps and method for detoxifying an lps-containing therapeutic liquid
11/08/1995CN1111284A Recombination vaccinia virus for expression of measles virus L4 strain hemagglutinin and fusion protein gene
11/08/1995CN1111158A Products containing G-CSF and TNF binding protein
11/07/1995US5464933 Synthetic peptide inhibitors of HIV transmission
11/07/1995US5464871 Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/07/1995US5464861 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
11/07/1995US5464848 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
11/07/1995US5464841 Use of delta opioid receptor antagonists to treat immunoregulatory disorders
11/07/1995US5464840 Tricyclic derivatives, compositions and methods of use
11/07/1995US5464829 Cephalosporin derivatives
11/07/1995US5464819 Physiologically active peptide having immunoregulatory activities
11/07/1995US5464796 7-isoindolinyl-quinolone-carboxylic acid derivatives
11/07/1995US5464621 Canine corona virus vaccine
11/07/1995US5464617 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics
11/07/1995US5464616 6β-substituted penicillanic acids as beta-lactamase inhibitors
11/07/1995CA2063872C Pharmaceutical preparation based on plasma proteins
11/07/1995CA2020590C Solid pharmaceutical composition containing a core and an outer layer
11/07/1995CA1337526C Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
11/07/1995CA1337523C Pyridonecarboxylic acids and antibacterial agents
11/03/1995CA2148312A1 Modified oligonucleotides, their preparation and their use
11/02/1995WO1995029248A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO)
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029190A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995WO1995029181A1 Substituted 5,6-dihydro-5-oxo-1,4-dithiino-(2,3-d)-pyridazine-2,3-dicarbonitriles, compositions containing them and their use as antimicrobials
11/02/1995WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties
1 ... 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 ... 1798